Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    PureTech Health

    NASDAQ: PRTC · Real-Time Price · USD
    17.48
    -0.46 (-2.56%)
    At close: Jun 27, 2025, 3:43 PM
    17.15
    -1.89%
    After-hours: Jun 27, 2025, 04:00 PM EDT

    PureTech Health Statistics

    Share Statistics

    PureTech Health has 24.02M shares outstanding. The number of shares has increased by 8.48% in one year.

    Shares Outstanding

    n/a
    		 24.02M

    Shares Change (YoY)

    n/a
    		 8.48%

    Shares Change (QoQ)

    n/a
    		 0.32%

    Owned by Institutions (%)

    n/a
    		 0.14%

    Shares Floating

    n/a
    		 164.8M

    Failed to Deliver (FTD) Shares

    n/a
    		 66

    FTD / Avg. Volume

    n/a
    		 1.18%

    Short Selling Information

    The latest short interest is 8.3K, so 0.03% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.3K

    Short % of Shares Out

    n/a
    		 0.03%

    Short % of Float

    n/a
    		 0.05%

    Short Ratio (days to cover)

    n/a
    		 1.72

    Valuation Ratios

    The PE ratio is 9.3 and the forward PE ratio is -3.14. PureTech Health's PEG ratio is -0.09.

    PE Ratio

    n/a
    		 9.3

    Forward PE

    n/a
    		 -3.14

    PS Ratio

    n/a
    		 115.36

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 1.2

    P/FCF Ratio

    n/a
    		 -3.7

    PEG Ratio

    n/a
    		 -0.09
    Financial Ratio History

    Enterprise Valuation

    PureTech Health has an Enterprise Value (EV) of 4.72B.

    EV / Sales

    n/a
    		 1093.77

    EV / EBITDA

    n/a
    		 126.25

    EV / EBIT

    n/a
    		 -35.12

    EV / FCF

    n/a
    		 -35.12

    Financial Position

    The company has a current ratio of 9.33, with a Debt / Equity ratio of 0.05.

    Current Ratio

    n/a
    		 9.33

    Quick Ratio

    n/a
    		 9.33

    Debt / Equity

    n/a
    		 0.05

    Debt / EBITDA

    n/a
    		 0.6

    Debt / FCF

    n/a
    		 -0.17

    Interest Coverage

    n/a
    		 -13.56

    Financial Efficiency

    Return on Equity is 12.9% and Return on Invested Capital is -27.95%.

    Return on Equity

    n/a
    		 12.9%

    Return on Assets

    n/a
    		 8.88%

    Return on Invested Capital

    n/a
    		 -27.95%

    Revenue Per Employee

    n/a
    		 $53,937.5

    Profits Per Employee

    n/a
    		 $668,875

    Employee Count

    n/a
    		 80

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -4.01M

    Effective Tax Rate

    n/a
    		 -16.86%

    Stock Price Statistics

    The stock price has increased by -31.14% in the last 52 weeks. The beta is 0.9, so PureTech Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.9

    52-Week Price Change

    n/a
    		 -31.14%

    50-Day Moving Average

    n/a
    		 17.78

    200-Day Moving Average

    n/a
    		 19.04

    Relative Strength Index (RSI)

    n/a
    		 48.72

    Average Volume (20 Days)

    n/a
    		 5,585

    Income Statement

    In the last 12 months, PureTech Health had revenue of 4.32M and earned 53.51M in profits. Earnings per share was 2.

    Revenue

    n/a
    		 4.32M

    Gross Profit

    n/a
    		 4.32M

    Operating Income

    n/a
    		 -136.09M

    Net Income

    n/a
    		 53.51M

    EBITDA

    n/a
    		 37.38M

    EBIT

    n/a
    		 33.81M

    Earnings Per Share (EPS)

    n/a
    		 2
    Full Income Statement

    Balance Sheet

    The company has 280.64M in cash and 22.36M in debt, giving a net cash position of 258.28M.

    Cash & Cash Equivalents

    n/a
    		 280.64M

    Total Debt

    n/a
    		 22.36M

    Net Cash

    n/a
    		 258.28M

    Retained Earnings

    n/a
    		 32.49M

    Total Assets

    n/a
    		 602.63M

    Working Capital

    n/a
    		 344.87M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -134.37M and capital expenditures -11K, giving a free cash flow of -134.38M.

    Operating Cash Flow

    n/a
    		 -134.37M

    Capital Expenditures

    n/a
    		 -11K

    Free Cash Flow

    n/a
    		 -134.38M

    FCF Per Share

    n/a
    		 -0.5
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -3154% and 1240.09%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -3154%

    Pretax Margin

    n/a
    		 550.96%

    Profit Margin

    n/a
    		 1240.09%

    EBITDA Margin

    n/a
    		 866.33%

    EBIT Margin

    n/a
    		 -3154%

    FCF Margin

    n/a
    		 -3114.25%

    Dividends & Yields

    PRTC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 10.75%

    FCF Yield

    n/a
    		 -2.7%
    Dividend Details

    Analyst Forecast

    The average price target for PRTC is $45, which is 166.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $45

    Price Target Difference

    n/a
    		 166.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $50

    Lynch Upside

    n/a
    		 196.38%

    Graham Number

    n/a
    		 2.62

    Graham Upside

    n/a
    		 -84.47%

    Scores

    Altman Z-Score

    n/a
    		 1.24

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist